View Post

London's Poliovirus Confirmations Continue Unabated

In COVID-19, Latest News by Precision Vaccinations

The U.K. Health Security Agency (UKHSA) recently announced it continues investigating the source of the poliovirus identified in wastewater systems across London, England.
The UKHSA stated on October 19, 2022, it is most likely that an individual entered the U.K. in February 2022 from a country where the oral polio vaccine (OPV) had been used for immunization campaigns. 
Recently vaccinated individuals can shed the OPV virus in their stool for a few weeks following vaccination enabling the virus to be detected through sewage surveillance.

View Post

Flu Shots Flopped Last Season

In Influenza Vaccine News by Influenza Vaccine

During the two-day U.S. CDC Advisory Committee on Immunization Practices (ACIP) meeting led by Dr. Grace Lee, several presentations revealed significant vaccine progress and measurable health impact.
However, when Jessie Chung MPH, Samantha Olson MPH, and Nathaniel Lewis Ph.D. presented the preliminary influenza vaccine efficacy (VE) results from the last flu season, various ACIP members expressed shock and dismay.

View Post

Flu Shots Flopped Last Season

In COVID-19, Latest News by Precision Vaccinations

During the two-day U.S. CDC Advisory Committee on Immunization Practices (ACIP) meeting led by Dr. Grace Lee, several presentations revealed significant vaccine progress and measurable health impact.
However, when Jessie Chung MPH, Samantha Olson MPH, and Nathaniel Lewis Ph.D. presented the preliminary influenza vaccine efficacy (VE) results from the last flu season, various ACIP members expressed shock and dismay.

View Post

Monkeypox Vaccination Produced de Minimis Protection

In COVID-19, Latest News by Precision Vaccinations

When the monkeypox outbreak began in May 2022, most impacted people started a search for a preventive vaccine. In the U.S., the government began offering vaccinations in Boston, then in New York and Washington DC.
But without peer-reviewed clinical studies, vaccine efficacy remained in question. 
A recent study published by the journal Nature Medicine found the antibody response to the two-dose JYNNEOS® (MVA-BN) vaccine in non-primed people or those who had not previously received a smallpox vaccine was very low.